Comes Harmony, a prenatal test created in the United States to discover non-invasively the risk of chromosomal disorders.

A prenatal test able to detect the risk of chromosomal disorders without risks? There, it is called Harmony and from March can be prescribed in Italy, in the Analysis Center of Monza. The test replaces the riskiest tests of chorionic villus sampling and amniocentesis. However, there are some details not up to standard, which make the test still unreliable.

What’s this?

“The Harmony prenatal testing – we read on the site of the CAM Analysis Center of Monza – is a non-invasive and risk-free run on the mother’s blood , which analyzes the risk of fetal trisomies most common aneuploidy and X, Y in pregnancies from the tenth week onwards’ . In short, a test that consists of a simple analysis of maternal plasma and thanks to which you can trace most common chromosomal abnormalities of the fetus – as Down syndrome, Edwards syndrome and Patau syndrome – without having to resort to more invasive tests such as chorionic villus sampling and amniocentesis . Testing was designed and produced by the U.S. Airy Diagnostics and its price is between 795 and 900 dollars. In Italy, the test is available from the month of March and the CAM Monza is for now the only Italian center where you can do so . Currently, however, is available only for high-risk women over the age of 35 years. “Thanks to this test – Andreani said Marianna, a specialist in obstetrics and gynecology of the Fetal Medicine Foundation – amniocentesis would disappear, and will be limited to those who present positivity in this test or a family history that makes the pregnancy at risk.


The cons

has conducted a survey on prenatal testing Harmony, highlighting some flaws. First of all, the presence of many false positives, tests that diagnose an anomaly that in reality does not show up to the birth of the child. This fact would make the test unable to predict the presence of a chromosomal disorder; why some members of the American College of Medical Genetics and Genomics have proposed to consider the test as evaluation of risks, not as a diagnostic .

The second neo found in the Harmony Test is the lack of approval of the Food and Drug Administration, the U.S. agency in charge of drug safety. In addition, prenatal testing does not bear the CE mark on the packaging that is used to certify the validity of the drug in Europe. Perhaps, before we talk about a miraculous test, you should solve these simple “paperwork” related to it.